Reduced EphA5 expression has been associated with nodal metastasis, advanced TNM stages, and poor prognosis in CRC, indicating that EphA5 may be acting as a tumor suppressor. Indeed, EFNA5 expression has been correlated with attenuating CRC cell migration and invasion. This evidence concerns the gene EPHA5 and colorectal carcinoma.